Transcriptomics

Dataset Information

0

PABPC1L promotes tryptophan metabolism and immune suppression by stabilizing IDO1 in renal cell carcinoma


ABSTRACT: The tumor microenvironment (TME) in renal cell carcinomas (RCC) is marked by substantial immunosuppression and immune resistance though highly infiltrated by T cells. There is an urgent need to elucidate tumor immune evasion and to develop novel therapeutic target to boost the efficacy of immune checkpoint blockade (ICB) in RCC. Our study uncovers a mechanism wherein the polyadenylate-binding protein PABPC1L modulates indoleamine2, 3dioxygenase1 (IDO1), a prospective candidate for immunotherapy. PABPC1L, markedly upregulated in RCC, correlates with unfavorable prognosis and resistance to ICB. Overexpressed PABPC1L bolsters tryptophan metabolism and induces T-cell dysfunction by stabilizing IDO1. Conversely, silencing PABPC1L diminishes IDO1 expression, mitigates cytotoxic T-cell suppression, and enhances responsiveness to anti-PD-1 therapy. Our findings underscore PABPC1L's crucial role in facilitating immune evasion in RCC, making it a potential addition to ICB therapy.

ORGANISM(S): Homo sapiens

PROVIDER: GSE241871 | GEO | 2024/02/14

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2024-02-14 | GSE255448 | GEO
2013-11-01 | E-GEOD-41980 | biostudies-arrayexpress
2023-07-25 | GSE234732 | GEO
2020-04-06 | GSE130679 | GEO
2023-01-16 | GSE198460 | GEO
2021-12-10 | GSE175700 | GEO
2013-11-01 | GSE41980 | GEO
2022-05-05 | PXD033718 |
2022-01-11 | GSE174116 | GEO
2021-12-06 | PXD024369 | Pride